Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
 
 
 

Our company in China

Our company has been operating in China for 83 years now and meanwhile has 3,100 employees working in production, research and development as well as marketing and sales in this growth market. Products and services from all three of our business sectors – Healthcare, Life Science and Performance Materials – are sold in China.
 

Investing in the growth market of China

According to IMS Health estimates, China is expected to become the world’s second-largest pharmaceutical market by 2018. That’s why we are boosting our investments in this country. In Nantong, an industrial city located 140 km north of Shanghai, we have now opened a new pharmaceutical manufacturing site that will produce medicines on China’s Essential Drugs List for the treatment of diabetes, cardiovascular disease and thyroid disorders.
Additionally, we will start in 2017 with the construction of a Life Science Center also located in Nantong in order to offer products and services for the Chinese pharmaceutical and biopharmaceutical industries.
Our company invests around € 170 million in the construction of the pharmaceutical manufacturing site. The investment in the Life Science Center is estimated at around € 80 million.

PRESS MATERIAL

Press Material
Merck KGaA, Darmstadt, Germany, Invests € 250 Million in Production Value Chain in China

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

CONTACT

Gangolf Schrimpf
GANGOLF SCHRIMPF
Healthcare
Tel: +49 6151 72-9591
Fax: +49 6151 72-919591
Merck KGaA, Darmstadt, Germany on Facebook
Merck KGaA, Darmstadt, Germany on LinkedIn
Merck on Slideshare